Ask AI

ARTifactual Intelligence: Enhance Your Skills in Selecting and Switching ART Regimens Through AI-Adaptive Cases

Since its inception, antiretroviral therapy (ART) for HIV has been characterized by frequent new developments and updates to best practices and guidelines. Modern ART regimens have enabled optimization of treatment for every person living with HIV, no matter their life stage or unique health needs. Boost your confidence in navigating ART initiation and ART optimization with these AI-adaptive cases, which leverage PRISM-ID, a Johns Hopkins–designed custom AI learning agent for HIV medicine, and feature personalized, adaptive educational case scenarios including assessments of knowledge and clinical reasoning.

Share

Program Content

Activities

First Steps After HIV Diagnosis
First Steps After New HIV Diagnosis
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 12, 2026

Expires: August 11, 2027

ART Switch With Enteral Administration Challenges
Considering ART Switch in a Patient With Enteral Administration Challenges
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2026

Expires: September 15, 2027

CV Risk in HIV
Cardiovascular Risk Management in a Person With HIV
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2026

Expires: September 15, 2027

ART in Pregnancy
Initiating Antiretroviral Therapy in Pregnancy
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2026

Expires: August 27, 2027

Rising Serum Creatinine While on ART
Rising Serum Creatinine While on ART: What to Do
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: September 24, 2026

Expires: September 23, 2027

ART and Weight Gain
ART Selection in the Setting of Weight Gain
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2026

Expires: August 27, 2027

Salvage Therapy
Selecting Salvage Therapy After Virologic Failure 
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2026

Expires: August 27, 2027

Potential Seroconversion on PrEP
Potential Seroconversion on Long-Acting PrEP: Navigating the Possibilities
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: September 02, 2026

Expires: September 01, 2027

ART With Opportunistic Infection
Antiretroviral Therapy Initiation in the Setting of Opportunistic Infection
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: August 28, 2026

Expires: August 27, 2027

Viremia and Adherence
Viremia in Someone With Adherence Challenges
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: September 02, 2026

Expires: September 01, 2027

Activities

Optimizing ART Initiation and Switching Strategies
Optimizing ART: Initiation and Switching Strategies in Viral Suppression and Viremia
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: September 03, 2026

Expires: September 02, 2027

Optimizing ART Initiation and Switching Strategies Slides
Optimizing ART Slides: Initiation and Switching Strategies in Viral Suppression and Viremia
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: September 02, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc. and Merck & Co., Inc., Rahway, NJ, USA.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA